PDT Partners’s Medtronic MDT Stock Holding History

PDT Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,800	Closed	-$522K	–	780
2024 Q3	$522K	Buy	+5,800	New	+$488K	0.05%	496
2022 Q3	–	Sell	-5,900	Closed	-$530K	–	979
2022 Q2	$530K	Buy	+5,900	New	+$598K	0.05%	583
2021 Q2	–	Sell	-6,100	Closed	-$721K	–	902
2021 Q1	$721K	Buy	+6,100	New	+$715K	0.05%	428
2015 Q3	–	Sell	-454,887	Closed	-$33.7M	–	1446
2015 Q2	$33.7M	Buy	+454,887	New	+$34.8M	0.88%	11
2014 Q4	–	Sell	-460,427	Closed	-$28.5M	–	900
2014 Q3	$28.5M	Buy	+460,427	New	+$29.3M	0.72%	13
2014 Q1	–	Sell	-7,800	Closed	-$448K	–	1336
2013 Q4	$448K	Sell	7,800 -41,800	-84%	-$2.37M	0.05%	458
2013 Q3	$2.64M	Buy	+49,600	New	+$2.67M	0.07%	380

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PDT Partners's MDT Position: Q4 2024 in Review

PDT Partners sold out of Medtronic (MDT) in Q4 2024, closing a stake of 5,800 shares — an estimated $522K sold.

PDT Partners first reported a position in MDT in Q3 2013 and held it in 7 quarters. The position peaked at $33.7M in Q2 2015. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

PDT Partners reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
PDT Partners sold 5,800 Medtronic shares in Q4 2024, an estimated $522K.
PDT Partners first reported a position in Medtronic in Q3 2013 and held it in 7 quarters.
PDT Partners's Medtronic position peaked at $33.7M in Q2 2015.
2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.